Reklaim Ltd Sets August Meeting Date Amid New Equity Grants

Alongside the meeting announcement, the board of directors confirmed a fresh round of equity compensation. The company approved the grant of 3,581,999 stock options and 1,099,999 restricted share units under its Omnibus Incentive Plan. These stock options carry an exercise price of $0.06 per share and remain valid for three years, while the restricted share units were issued at a deemed value of $0.04 each, pending final approval from the TSX Venture Exchange.

Investors can access full meeting documentation, including the management information circular, through the SEDAR+ platform or the company’s dedicated investor relations portal. Reklaim, which operates a platform focused on individual data monetization and privacy protection, continues to provide consent-based audience insights to advertising brands while maintaining its core focus on consumer information control.